AMPLIFYBIO
AmplifyBio is a biotechnology company that develops next-generation cell and gene therapies. The company's mission is to create pathways for novel treatment advances, cutting-edge technologies, and new research frontiers to advance medical breakthroughs, treatments, and cures for disease. AmplifyBio was founded in 2021 and is headquartered in West Jefferson, OH.
AMPLIFYBIO
Industry:
Biotechnology Health Care Life Science
Founded:
2021-01-01
Address:
West Jefferson, Ohio, United States
Country:
United States
Website Url:
http://www.amplify-bio.com
Total Employee:
251+
Status:
Active
Contact:
833-641-2006
Total Funding:
279.75 M USD
Technology used in webpage:
Domain Not Resolving Amazon Person Schema Office 365 Mail Gravatar Profiles Amazon Virginia Region Unified Layer BlueHost
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Current Employees Featured
Jerry Hacker EVP And Chief Commercial Officer @ AmplifyBio
EVP And Chief Commercial Officer
Harry Ledebur VP & GM, CRO Operations @ AmplifyBio
VP & GM, CRO Operations
2021-05-01
J. Kelly Ganjei Founder, President & Chief Executive Officer @ AmplifyBio
Founder, President & Chief Executive Officer
2021-05-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-10-03 | PACT Pharma - Assets | PACT Pharma - Assets acquired by AmplifyBio | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - AmplifyBio
Viking Capital
Viking Capital investment in Venture Round - AmplifyBio
Narya Capital
Narya Capital investment in Venture Round - AmplifyBio
Battelle
Battelle investment in Venture Round - AmplifyBio
Official Site Inspections
http://www.amplify-bio.com Semrush global rank: 4.18 M Semrush visits lastest month: 2.42 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Amplify-bio.com lookup results from whois.squarespace.domains server:
- Domain created: 9th-Feb-2021
- Domain updated: 16th-Jan-2025
- Domain expires: 9th-Feb-2026 0 Years, 310 Days left
- Website age: 4 Years, 54 Days
- Registrar Domain ID: 2590378863_DOMAIN_COM-VRSN
- Registrar Url: http://domains2.squarespace.com
- Registrar WHOIS Server: whois.squarespace.domains
- Registrar Abuse Contact Email: abuse-complaints@squarespace.com
- Registrar Abuse Contact Phone: +1.6466935324
- Name server:
- NS1-06.AZURE-DNS.COM
- NS2-06.AZURE-DNS.NET
- NS3-06.AZURE-DNS.ORG
- NS4-06.AZURE-DNS.INFO
More informations about "AmplifyBio"
AmplifyBio - Advanced Therapy CDMO
AmplifyBio is a concept to commercial CRO dedicated to providing expert services for drug discovery, characterization, optimization, in vitro and in vivo safety studies, and manufacturing …See details»
AmplifyBio Latest News | AmplifyBio
Dec 20, 2024 AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture AmplifyBio, a Contract Development and Manufacturing …See details»
AmplifyBio - Crunchbase Company Profile & Funding
Organization. AmplifyBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact …See details»
AmplifyBio 2025 Company Profile: Valuation, Funding …
AmplifyBio General Information Description. Operator of a biotechnology platform intended to advance the quality of human health and save lives. The …See details»
AmplifyBio shutters Bay Area site, lays off Ohio CRO staff
Dec 6, 2024 Amplify layoffs contract research organization facilities. AmplifyBio is cutting costs, closing its R&D and characterization services site in South San Francisco and laying off …See details»
AmplifyBio - APT Oncology
AmplifyBio AmplifyBio will advance the quality of human health and save lives by creating next generation platforms, tools, and services to amplify and accelerate the development of …See details»
AmplifyBio | Top 20 Pharma And Life Sciences Tech …
AmplifyBio partners with clients to provide a single preclinical study or full IND enabling programs with a strategic focus on clients developing advanced therapies. The organization is still delivering excellence in the safety, efficacy, …See details»
AmplifyBio - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 27, 2025 AmplifyBio - Provider of contract research, development, and manufacturing services for biologic drugs. Raised a total funding of $230M over 4 rounds from 2 investors. …See details»
Preclinical CRO Services - AmplifyBio
Organization Services. Whether you’re developing a traditional small molecule drug or advanced therapies, AmplifyBio is a preclinical CRO with the experience and capabilities to guide you through a single study or a full IND-enabling …See details»
AmplifyBio - VentureRadar
Similar Companies: ElevateBio USA Privately Held ElevateBio, LLC, is a Cambridge-based biotechnology holding company, established to create and operate a broad portfolio of cell and …See details»
AmplifyBio and RNAV8 Bio Announce Strategic Partnership to
Apr 16, 2024 About Amplify Bio: AmplifyBio is a contract research and manufacturing organization founded on the principle that all development and scale-up of advanced modality …See details»
AmplifyBio Expands in the Columbus Region, Investing $150 …
May 23, 2022 AmplifyBio, a biotechnology contract research organization (CRO) that aims to advance the quality and innovation of human health and advanced therapies, is expanding in …See details»
Media Room of AmplifyBio
News Apr 16, 2024 AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture . AmplifyBio, a Contract …See details»
AmplifyBio Company Overview, Contact Details & Competitors
Nov 15, 2023 AmplifyBio LLC launched T-cell receptor therapies targeting solid tumors on May 20th '24. SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)-Xcell …See details»
Make a Difference with a Life Sciences Career - AmplifyBio
Explore AmplifyBio's life science jobs and careers in preclinical research to help shape the future of medicine. AmplifyBio combines the experience of our multi-disciplinary teams to advance …See details»
AmplifyBio Expands Its Vision: Launches Advanced Therapy
NEW ALBANY, Ohio, November 28, 2023 (Newswire.com) - AmplifyBio, a leading contract research organization, is announcing the opening of a new business unit to further expand its …See details»
AmplifyBio and RNAV8 Bio Form Strategic Partnership to Assist …
Apr 17, 2024 AmplifyBio, a Contract Development and Manufacturing Organization and Contract Research Organization, and RNAV8 Bio, a rising startup specializing in mRNA engineering …See details»
Cell & Gene Advanced Therapy Discovery Services - AmplifyBio
We apply this experience across business units to offer cell therapy R&D services, including everything from preclinical research to clinical-grade production. Our contract research …See details»
AmplifyBio Expands Into Columbus, OH | AmplifyBio
AmplifyBio Announced in May Plans to Expand Into the Columbus Region May 23, 2022. Columbus, Ohio – AmplifyBio, a biotechnology contract research organization (CRO) that aims …See details»
Enhancing Preclinical Toxicity Studies: Targeted Tissue …
3 days ago Rapid and flexible safety assessments are paramount in the rapidly evolving field of advanced therapies. Delaying the evaluation of target tissues can result in significant setbacks …See details»